Physiologic surface-active agents and drug absorption. IV. Effect of pre-micellar concentrations of surfactant on dissolution rate.
D001241:Aspirin / Q000378:metabolism; D001647:Bile Acids and Salts / Q000494:pharmacology; D002021:Buffers; D002214:Capsules; D004987:Ethers / Q000494:pharmacology; D005750:Gastric Juice / Q000502:physiology*; D005752:Gastric Mucins / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D008244:Lysophosphatidylcholines / Q000494:pharmacology; D010434:Pepsin A / Q000494:pharmacology; D011208:Powders; D012457:Salicylamides / Q000378:metabolism; D012459:Salicylates / Q000378:metabolism; D012995:Solubility; D013053:Spectrophotometry; D013500:Surface Tension; D013501:Surface-Active Agents / Q000494:pharmacology* / Q000502:physiology*; D013607:Tablets
D001647:Bile Acids and Salts; D002021:Buffers; D002214:Capsules; D004987:Ethers; D005752:Gastric Mucins; D008244:Lysophosphatidylcholines; D011208:Powders; D012457:Salicylamides; D012459:Salicylates; D013501:Surface-Active Agents; D013607:Tablets; D010434:Pepsin A; D001241:Aspirin